Physician profile
Steve S Lee
NPI 1972583490
$977.27
in general payments reported to CMS, 2019-2025
11 companies · $79.91 in 2025
The $79.91 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.11 · 2022: $166 · 2023: $247 · 2024: $464 · 2025: $79.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $790.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $226.74 | 2023 | Xience Skypoint, Amplatzer Amulet |
| Shockwave Medical, INC | $207.94 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $142.37 | 2022 | |
| Scpharmaceuticals INC. | $126.51 | 2024 | |
| Abiomed | $99.87 | 2024 | Impella |
| Medtronic, INC. | $56.98 | 2025 | Cobalt Dr Mri Surescan |
| Asahi Intecc USA, INC. | $30.11 | 2024 | Peripheral Vascular |
| Cmp Pharma, INC. | $23.84 | 2022 | |
| Amgen INC. | $22.93 | 2025 | Repatha |
| Boston Scientific Corporation | $20.11 | 2019 | |
| Penumbra, INC. | $19.87 | 2023 | Penumbra System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.